Published in Heart Rhythm on February 28, 2006
Pulmonary vein isolation with Mesh Ablator versus cryoballoon catheters: 6-month outcomes. J Interv Card Electrophysiol (2010) 0.80
Introduction of an expert system for the discrimination of local pulmonary vein and atrial far field signals. J Interv Card Electrophysiol (2010) 0.75
Clinical experience with routine use of a single combined mapping and ablation catheter for isolation of pulmonary veins in patients with paroxysmal atrial fibrillation. Wien Klin Wochenschr (2010) 0.75
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med (2015) 6.68
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med (2002) 4.89
Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation (2005) 4.75
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation (2008) 4.43
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37
Mapping and ablation of idiopathic ventricular fibrillation. Circulation (2002) 3.69
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol (2013) 3.08
The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm (2012) 2.87
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation (2012) 2.80
Technique and results of linear ablation at the mitral isthmus. Circulation (2004) 2.74
Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol (2004) 2.63
Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation (2004) 2.63
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation (2003) 2.56
Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation (2004) 2.50
Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol (2008) 2.50
Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol (2012) 2.40
Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc Electrophysiol (2002) 2.36
The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med (2012) 2.31
Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J (2013) 2.29
Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc (2013) 2.28
Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". J Am Coll Cardiol (2009) 2.27
Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol (2007) 2.25
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol (2011) 2.21
Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm (2010) 2.19
Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation. Europace (2013) 2.14
Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins. Eur Heart J (2005) 2.14
Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J Am Coll Cardiol (2009) 2.12
High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm (2006) 2.10
Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol (2011) 2.04
"Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol (2004) 2.00
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol (2009) 1.98
Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm (2010) 1.95
A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm (2011) 1.95
A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J (2012) 1.91